methylprednisolone acetate has been researched along with Cardiomyopathies in 1 studies
Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ober, MD | 1 |
| Del Priore, LV | 1 |
| Tsai, J | 1 |
| Lopez, R | 1 |
| Lobes, LA | 1 |
| Puklin, JE | 1 |
| Young, T | 1 |
1 other study available for methylprednisolone acetate and Cardiomyopathies
| Article | Year |
|---|---|
Diagnostic and therapeutic challenges.
Topics: Adolescent; Anemia; Anti-Inflammatory Agents; Cardiomyopathies; Epoetin Alfa; Erythropoietin; Fluore | 2006 |